[Results of phase Ib open multicenter clinical trial of the safety, pharmacokinetics and pharmacodynamics of first biosimilar of eculizumab in untreated patients with paroxysmal nocturnal hemoglobinuria during induction of therapy].
Ter Arkh
; 92(7): 77-84, 2020 Sep 01.
Article
en Ru
| MEDLINE
| ID: mdl-33346448
Palabras clave
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Biosimilares Farmacéuticos
/
Hemoglobinuria Paroxística
Tipo de estudio:
Clinical_trials
Límite:
Adult
/
Aged
/
Humans
/
Middle aged
País/Región como asunto:
Asia
/
Europa
Idioma:
Ru
Revista:
Ter Arkh
Año:
2020
Tipo del documento:
Article